Amanita Muscaria
Stats & Data
Fly agaric
Chemical Class
Botanical preparation
Psychoactive Class
Depressant / Psychedelic
Effect Profile
Curated
+ 198 Reports
Strong visuals, auditory effects, and headspace with strong body load
Visual Intensity×3
10104.0
Headspace Depth×3
95.52.6
Auditory Effects×1
108.11.5
Body Load / Somatic Effects×1
99.76.8
Catalog
Erowid
BlueLight
Empirical Duration
Erowid Reports
Median times after the dose that Erowid reports state. A curve is drawn only when reports state all four points (onset, peak begins, comedown begins, back to baseline) and the medians fall in that order. No point is estimated from another.
Oral
(36 reports)
Onset T+30min22 reports
Peak begins T+3.5h6 reports
Comedown begins T+30min5 reports
Back to baseline T+7h5 reports
No curve:
the stated times run backwards.
Reports put the start of the comedown (T+30min, 5 reports) before the start of the peak (T+3.5h, 6 reports).
Each time is the median of a different set of reports, so they are shown as stated, not rearranged.
Experience Report Analysis
Erowid
BlueLight
292
Reports
185
Single-substance
1993–2024
Date Range
96
With Age Data
32
Effects Detected
Effect Analysis
Erowid + Bluelight
Effects aggregated from
198 experience reports
(185 single-substance Erowid + 13 Bluelight)
198
Reports
88
Effects Detected
42
Positive
27
Adverse
19
Neutral
Effect Sentiment Distribution
Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.
Rows resting on fewer than 20 reports show a count (“3 of 7”) instead of a bar. Why 20?
Positive Effects 42
Sedation
33.3%27–40% (95% interval 27 to 40 percent)
84%
Stimulation
31.3%25–38% (95% interval 25 to 38 percent)
75%
Euphoria
29.3%23–36% (95% interval 23 to 36 percent)
88%
Color Enhancement
27.8%22–34% (95% interval 22 to 34 percent)
84%
Empathy
17.1%13–23% (95% interval 13 to 23 percent)
80%
Music Enhancement
14.6%10–20% (95% interval 10 to 20 percent)
80%
Introspection
13.6%10–19% (95% interval 10 to 19 percent)
78%
Tactile Enhancement
12.1%8–17% (95% interval 8 to 17 percent)
85%
Focus Enhancement
7.0%4–12% (95% interval 4 to 12 percent)
70%
Body High
7.0%4–12% (95% interval 4 to 12 percent)
78%
Creativity Enhancement
3.2%2–7% (95% interval 2 to 7 percent)
70%
Pain Relief
2.7%1–6% (95% interval 1 to 6 percent)
70%
Depersonalization
4 of 13
81%
Contentment
3 of 13
78%
Geometric Imagery
3 of 13
85%
Visual Clarity
3 of 13
82%
Vivid Dreams
3 of 13
87%
Insight
3 of 13
78%
Lightness
2 of 13
82%
Lucidity
2 of 13
88%
Adverse Effects 27
Nausea
49.0%42–56% (95% interval 42 to 56 percent)
83%
Anxiety
37.9%31–45% (95% interval 31 to 45 percent)
72%
Confusion
23.2%18–30% (95% interval 18 to 30 percent)
75%
Sweating
19.7%15–26% (95% interval 15 to 26 percent)
90%
Memory Suppression
13.5%9–19% (95% interval 9 to 19 percent)
70%
Motor Impairment
11.7%8–17% (95% interval 8 to 17 percent)
85%
Thought Loops
7.0%4–12% (95% interval 4 to 12 percent)
70%
⚠ Seizure
4.9%3–9% (95% interval 3 to 9 percent)
70%
Muscle Tension
4.9%3–9% (95% interval 3 to 9 percent)
70%
Headache
3.2%2–7% (95% interval 2 to 7 percent)
70%
Pupil Dilation
2.7%1–6% (95% interval 1 to 6 percent)
70%
Increased Heart Rate
2.2%1–5% (95% interval 1 to 5 percent)
70%
Vomiting
3 of 13
87%
Salivation
3 of 13
92%
Delusion
2 of 13
80%
Body Temperature Change
2 of 13
90%
Chills
2 of 13
90%
Ataxia
2 of 13
85%
Cold Flashes
2 of 13
80%
Paranoid Ideation
1 of 13
75%
Show 7 more adverse effects
Dizziness
1 of 13
80%
Hot Flashes
1 of 13
85%
Tremor
1 of 13
85%
Body Load
1 of 13
80%
Heaviness
1 of 13
75%
Muscle Spasm
1 of 13
85%
Sadness
1 of 13
70%
Show 19 neutral or unclassified mentions
Visual Distortions
33.3%27–40% (95% interval 27 to 40 percent)
Auditory Effects
20.2%15–26% (95% interval 15 to 26 percent)
Dissociation
15.6%11–21% (95% interval 11 to 21 percent)
Hospital
14.6%10–20% (95% interval 10 to 20 percent)
Closed-Eye Visuals
14.6%10–20% (95% interval 10 to 20 percent)
Time Distortion
10.6%7–16% (95% interval 7 to 16 percent)
Open-Eye Visuals
10.6%7–16% (95% interval 7 to 16 percent)
Ego Dissolution
2.2%1–5% (95% interval 1 to 5 percent)
Thought Acceleration
2 of 13
Thought Disorganization
2 of 13
Vibrating
1 of 13
Perspective Distortion
1 of 13
Time Dilation
1 of 13
Blurred Vision
1 of 13
Tingling
1 of 13
Insomnia
1 of 13
Visual Snow
1 of 13
Lightheadness
1 of 13
Thought Deceleration
1 of 13
Also reported in combinations.
In the 107 Amanita Muscaria reports where another drug was taken too,
8 (7.5%) mention hospital, emergency services or an overdose,
1 (0.9%) a seizure and 3 (2.8%) psychosis.
In the 185 single-substance reports:
14.6%, 4.9% and 1.1%.
These are not in the figures above: they cannot be put down to Amanita Muscaria alone, and a mention is not always something that happened to the writer.
Subjective Effect Ontology
Experience Reports
Structured effect tags extracted from 305
Erowid & Bluelight experience reports
using a controlled vocabulary of 220+ canonical effects across 15 domains.
Emotional
anxiety
118
38.7% (95% interval 33 to 44 percent)
Gastrointestinal
nausea
176
57.7% (95% interval 52 to 63 percent)
Motor
sedation
111
36.4% (95% interval 31 to 42 percent)
stimulation
109
35.8% (95% interval 31 to 41 percent)
Visual
visual distortions
133
45.5% (95% interval 40 to 51 percent)
5 unique effects extracted
· Derived from
Erowid & Bluelight reports
Dosage Distribution
Dose distribution from experience reports, one dose per report (the first listed). Doses above Q3 + 3×IQR, far above what people typically take, are left out of the median and range and listed under each route: most are real heavy doses or overdoses, not mistakes.
Median: 8000.0 mg
IQR: 5000.0–14000.0 mg
n=138
1 report gave a dose above the typical range
(45,000 mg), so it is not in the figures above.
Listing a dose here does not mean it is safe.
Show the report
Real-World Dose Distribution
Erowid
From 225 of 335 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.
Oral (n=214)
Median: 8000.0mg
25th: 5000.0mg
75th: 12875.0mg
90th: 19400.0mg
Smoked (n=9)
Median: 500.0mg
25th: 70.0mg
75th: 1000.0mg
90th: 1200.0mg
Common Combinations
Most co-occurring substances, as a share of all 292 reports filed under Amanita Muscaria; whiskers are 95% intervals
Form / Preparation
Most common forms and preparations, as a share of the 235 reports that give one; whiskers are 95% intervals
Body-Weight Dosing
Dose per kg of body weight, one dose per report (the first listed), from reports giving a weight of 30–250 kg. Doses above Q3 + 3×IQR, far above what people typically take, are left out of the median and range and listed under each route.
Median: 121.581 mg/kg
IQR: 74.625–174.249 mg/kg
n=131
1 report gave a dose above the typical range
(522.042 mg/kg), so it is not in the figures above.
Listing a dose here does not mean it is safe.
Show the report
Redose Patterns
Redosing behavior across 245 reports
20.4%16–26% (95% interval 16 to 26 percent)
Redosed
1.2
Avg Doses
60m
Median Interval
← Back to Amanita Muscaria
